在分子亚型小细胞肺癌 (SCLC) 中转向个性化方法
Anna Grenda1, Paweł Krawczyk1, Adrian Obara2
1Department of Pneumonology, Oncology and Allergology, Medical University of Lublin, 20-950 Lublin, Poland.
International journal of molecular sciences
|April 27, 2024
概括
小细胞肺癌 (SCLC) 治疗正在通过免疫检查点抑制剂和向疗法取得进展. SCLC的分子亚型提供了新的个性化治疗策略,以改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 肺部病理学 肺部病理学
- 癌症研究 癌症研究
背景情况:
- 小细胞肺癌 (SCLC) 是全球癌症死亡的主要原因,以侵略性生长和不良预后而闻名.
- SCLC通常在晚期 (广泛疾病,ED-SCLC) 诊断出具有远程转移的SCLC.
- 与烟草吸烟的关联很强,有助于其高死亡率.
研究的目的:
- 审查SCLC治疗的最新进展,重点关注免疫检查点抑制剂和向疗法.
- 突出SCLC分子细分对于个性化医学的重要性.
- 讨论量身定制的治疗策略的潜力,以改善患者的治疗结果.
主要方法:
- 审查最近的临床试验 (例如,CASPIAN,IMpower133),评估ED-SCLC第一线化疗中的免疫检查点抑制剂.
- 对新兴分子向疗法 (例如IGF-1R,DLL3,BCL-2,MYC,PARP抑制剂) 的分析.
- 对SCLC分子细分的转录和免疫组织化学分析的检查.
主要成果:
- 免疫检查点抑制剂与化疗相结合,在ED-SCLC患者中改善了无进展和整体存活率.
- 几种分子标 (IGF-1R,DLL3,BCL-2,MYC,PARP) 显示出未来向治疗的潜力.
- SCLC的分子细分揭示了具有激活通路的独特亚型,从而使个性化治疗方法成为可能.
结论:
- 免疫检查点抑制剂代表了广泛阶段SCLC的第一线治疗的重大进展.
- 对SCLC的分子分析对于确定个性化治疗策略至关重要,包括向疗法和免疫疗法.
- 量身定制的治疗方法有望显著改善SCLC患者的治疗结果.
更多相关视频
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
10.6K
08:52Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
4.0K
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K